Ilkay Irem Ozbek

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 10

Top Topics

Low Density Lipoprotein

Induced Apoptosis

Hyaluronic Acid

Top Venues

ACS biomaterials science & engineering

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Ilkay Irem Ozbek, Hale Saybasili, Kutlu O Ülgen
Applications of 3D Bioprinting Technology to Brain Cells and Brain Tumor Models: Special Emphasis to Glioblastoma. ACS biomaterials science & engineering 10 (5) (2024)
Ilkay Irem Ozbek, Hale Saybasili, Kutlu O Ülgen
Applications of 3D Bioprinting Technology to Brain Cells and Brain Tumor Models: Special Emphasis to Glioblastoma. ACS biomaterials science & engineering (2024)
Ilkay Irem Ozbek, Hale Saybasili, Kutlu O Ülgen
Applications of 3D Bioprinting Technology to Brain Cells and Brain Tumor Models: Special Emphasis to Glioblastoma. ACS biomaterials science & engineering 10 (5) (2024)
Ilkay Irem Ozbek, Hale Saybasili, Kutlu O Ülgen
Applications of 3D Bioprinting Technology to Brain Cells and Brain Tumor Models: Special Emphasis to Glioblastoma. ACS biomaterials science & engineering 10 (5) (2024)
Ilkay Irem Ozbek, Hale Saybasili, Kutlu O Ülgen
Applications of 3D Bioprinting Technology to Brain Cells and Brain Tumor Models: Special Emphasis to Glioblastoma. ACS biomaterials science & engineering 10 (5) (2024)
Ilkay Irem Ozbek, Hale Saybasili, Kutlu O Ülgen
Applications of 3D Bioprinting Technology to Brain Cells and Brain Tumor Models: Special Emphasis to Glioblastoma. ACS biomaterials science & engineering 10 (5) (2024)
Ilkay Irem Ozbek, Kutlu O Ülgen
Identification of Therapeutic Targets for Medulloblastoma by Tissue-Specific Genome-Scale Metabolic Model. Molecules (Basel, Switzerland) 28 (2) (2023)
Ilkay Irem Ozbek, Kutlu O Ülgen
Identification of Therapeutic Targets for Medulloblastoma by Tissue-Specific Genome-Scale Metabolic Model. Molecules (Basel, Switzerland) 28 (2) (2023)
Ilkay Irem Ozbek, Kutlu O Ülgen
Identification of Therapeutic Targets for Medulloblastoma by Tissue-Specific Genome-Scale Metabolic Model. Molecules (Basel, Switzerland) 28 (2) (2023)
Ilkay Irem Ozbek, Kutlu O Ülgen
Identification of Therapeutic Targets for Medulloblastoma by Tissue-Specific Genome-Scale Metabolic Model. Molecules (Basel, Switzerland) 28 (2) (2023)